Description Cobimetinib, marketed under the brand name COTELLIC, It is an prescription medication that has been approved cobimetinib (Cotellic) on November 10, 2015. The FDA approved cobimetinib in combination with vemurafenib (Zelboraf) to treat patients with unresectable or metastatic melanoma that has a BRAF V600E or V600K mutation. What is Cotellic (Cobimetinib) ? COTELLIC (cobimetinib) is indicated for the treatment of patients with unresectable or metastatic melanoma with a BRAF V600E or V600K mutation, in combination with ZELBORAF (vemurafenib). Cobimetinib is used with another medication (vemurafenib) to treat a type of skin cancer (melanoma). It works by slowing or stopping the growth of cancer cells. Source Content From US FDA How to order approved “Cotellic (Cobimetinib) for Tablets” Medicine? COTELLIC (Cobimetinib) Tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing COTELLIC and arranging delivery to your location, please get in touch with Mr. Rakesh at 91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
